Sign In
Buy INSM
$103.86
+0.130 (+0.125%)
At Close: Jun 03, 2026
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
04:33pm, Thursday, 30'th Jul 2020
Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OSI Systems Receives $5 Million Order to Provide Medical Sensors
12:30pm, Tuesday, 28'th Jul 2020
OSI Systems, Inc. (the "Company" or "OSI Systems") (NASDAQ: OSIS) today announced that its Optoelectronics division has received an order for approximately $5 million from a leading healthcare origina
OSI Systems Awarded $5 Million Contract to Develop Automated Detection of Biosecurity Risk Items
12:30pm, Monday, 27'th Jul 2020
OSI Systems, Inc. (the "Company" or "OSI Systems") (NASDAQ: OSIS) today announced that its Security division was awarded a contract from the Commonwealth Government of Australia represented through th
Insmed to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 6, 2020
12:00pm, Monday, 27'th Jul 2020
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its second qu
A Quick Analysis On Insmed's (NASDAQ:INSM) CEO Salary
12:25pm, Friday, 24'th Jul 2020
This article will reflect on the compensation paid to Will Lewis who has served as CEO of Insmed Incorporated...
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that the Committee for Medicinal
Steven Cohen Homes in on Otonomy by Expanding Stake
05:15pm, Wednesday, 15'th Jul 2020
Guru ups bet in biotech focused on ear-related disorders Continue reading...
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that ARIKAYCE® (amikacin liposome
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12:00pm, Monday, 06'th Jul 2020
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards
Non-Cystic Fibrosis Bronchiectasis (NCFB) - 2020 Pipeline Insight Report - ResearchAndMarkets.com
12:00am, Friday, 03'rd Jul 2020
The
OSI Systems Receives $60 Million in Orders to Provide Cargo Inspection Systems and Services
12:30pm, Monday, 29'th Jun 2020
OSI Systems, Inc. (the "Company" or "OSI Systems") (NASDAQ: OSIS) today announced that its Security division received orders valued at approximately $60 million from a U.S. customer to provide several
Hedge Funds Are Dumping OSI Systems, Inc. (OSIS)
09:26pm, Sunday, 28'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filing
Acceleron's Sotatercept Trial, And Other News: The Good, Bad And Ugly Of Biopharma
03:34pm, Sunday, 28'th Jun 2020
Acceleron's sotatercept phase 2 trial yields positive data. Insmed reports positive phase 2 data from the WILLOW study. Chiasma's Mycapssa capsules get FDA appr
Two Sigma Investments LP Sells 5,241 Shares of Insmed Incorporated (NASDAQ:INSM)
07:01am, Thursday, 25'th Jun 2020
Two Sigma Investments LP lessened its holdings in Insmed Incorporated (NASDAQ:INSM) by 10.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchan
